S427-0524 Screening compound: N-[(4-fluorophenyl)methyl]-3-{[5-(pyridin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}piperidine-1-carboxamide

S427-0524 Screening compound: N-[(4-fluorophenyl)methyl]-3-{[5-(pyridin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}piperidine-1-carboxamide
S427-0524 Screening compound: N-[(4-fluorophenyl)methyl]-3-{[5-(pyridin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}piperidine-1-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound S427-0524
N-[(4-fluorophenyl)methyl]-3-{[5-(pyridin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}piperidine-1-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S427-0524

Molecular Formula

C21H22FN5O2 (C21 H22 FN5 O2)

Compound Name

N-[(4-fluorophenyl)methyl]-3-{[5-(pyridin-3-yl)-1,2,4-oxadiazol-3-yl]methyl}piperidine-1-carboxamide

IUPAC name

N-[(4-fluorophenyl)methyl]-3-{[5-(pyridin-3-yl)-124-oxadiazol-3-yl]methyl}piperidine-1-carboxamide

SMILES

O=C(NCc(cc1)ccc1F)N1CC(Cc2noc(-c3cnccc3)n2)CCC1

InChI

InChI=1S/C21H22FN5O2/c22-18-7-5-15(6-8-18)12-24-21(28)27-10-2-3-16(14-27)11-19-25-20(29-26-19)17-4-1-9-23-13-17/h1,4-9,13,16H,2-3,10-12,14H2,(H,24,28)/t16-/m1/s1

InChI Key

DWYTZZCEAYJTOW-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD29006562

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

395.44

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.605

Distribution Coefficient, logD

2.512

Water Solubility, LogSw

-2.56

Polar Surface Area

68.877

Acid Dissociation Constant (pKa)

14.09

Base Dissociation Constant (pKb)

6.78

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

S427-0524 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

GPCR Targeted Library (31838 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with S427-0524 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S427-0524?
Check Price and Availability of S427-0524, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S427-0524 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S427-0524
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S427-0524
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S427-0524 available by request